Ditchcarbon
  • Customers
  1. Organizations
  2. Clinuvel Pharmaceuticals Limited
Public Profile
Pharmaceutical Preparation Manufacturing
AU
updated 8 days ago

Clinuvel Pharmaceuticals Limited

Company website

Clinuvel Pharmaceuticals Limited, often referred to simply as Clinuvel, is an innovative biopharmaceutical company headquartered in Australia. Founded in 2002, Clinuvel has established itself as a leader in the development of treatments for skin disorders, particularly those related to UV exposure and genetic conditions. The company operates primarily in Europe, North America, and Asia, focusing on the research and commercialisation of its unique product, SCENESSE® (afamelanotide), which is designed to protect against phototoxicity. Clinuvel's commitment to advancing medical science has led to significant milestones, including regulatory approvals in multiple regions. With a strong market position, the company is recognised for its pioneering approach to photoprotection and skin health, setting it apart in the biopharmaceutical industry.

DitchCarbon Score

How does Clinuvel Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

16

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Clinuvel Pharmaceuticals Limited's score of 16 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.

11%

Let us know if this data was useful to you

Clinuvel Pharmaceuticals Limited's reported carbon emissions

Clinuvel Pharmaceuticals Limited, headquartered in Australia, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. Consequently, there are no recorded Scope 1, 2, or 3 emissions to analyse. Additionally, Clinuvel has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). The company has not made any climate pledges or engaged in initiatives like CDP, RE100, or CA100, which are commonly adopted by organisations aiming to enhance their sustainability practices. In the absence of specific emissions data or reduction commitments, it is unclear how Clinuvel Pharmaceuticals Limited is addressing climate change or its carbon footprint. As the industry increasingly prioritises sustainability, it will be essential for Clinuvel to consider developing measurable climate strategies and reporting frameworks to align with global standards and stakeholder expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Clinuvel Pharmaceuticals Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Clinuvel Pharmaceuticals Limited is in AU, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Clinuvel Pharmaceuticals Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Vertex Pharmaceuticals

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

EVT Limited

AU
•
Recreational, cultural and sporting services (92)
Updated 17 days ago

Blackmores

AU
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Sarepta Therapeutics

US
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Sigma Healthcare

AU
•
Health and social work services (85)
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250917.4
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy